Search results
Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) possesses the right combination of the two key ingredients for a likely earnings beat...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 3 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
Reuters· 3 days ago, opens new tab shareholders to vote against the re-election of three directors and proposals...
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational...
FOX 23 News Albany· 2 days agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter 2024 financial ...
Shah Capital seeks board overhaul at Novavax By Investing.com
Investing.com· 2 days agoShah Capital Management, a major shareholder in Novavax Inc. (NASDAQ:NVAX), has publicly expressed...
Novavax, Inc. (NASDAQ:NVAX) Shares Sold by Federated Hermes Inc.
ETF DAILY NEWS· 3 days agoFederated Hermes Inc. lowered its position in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 88.6% in the fourth quarter, according to the company in its most recent ...
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 14 hours ago“The key reason for the withdrawal is likely to be that other Covid vaccines, such as Pfizer and Moderna, are essentially better products. AstraZeneca is...
An adjuvant made in yeast could lower vaccine cost and boost availability
UC Berkeley NewsCenter· 21 hours agoVaccines save lives, as proven during the recent pandemic, but one component of most vaccines —...
Novavax investor Shah Capital to vote against three directors
Reuters via Yahoo Finance· 3 days agoMay 6 (Reuters) - Hedge fund Shah Capital said on Monday that it intends to vote against election of three directors on the board of COVID-19 vaccine maker Novavax. Shah Capital ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 12 hours agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...